Naturex enhances prostate health category with Flowens

More than 50% of men in their 50s and 80% of men in their 70s suffer from Benign Prostatic Hyperplasia (BPH) resulting in a potential market of over 26 million men in the US alone. Unfortunately, the effectiveness of leading botanicals in the prostate health category, such as saw palmetto, has recently come into question. According to the US National Center for Complimentary and Alternative Medicine (NCCAM), saw palmetto at double and triple the recommended doses is no more effective than a placebo.

Naturex, the global leader in natural specialty ingredients, realized the need for an improved botanical solution for prostate health and has introduced Flowens, the first full-spectrum cranberry-based ingredient specifically engineered for men’s health using a patent-pending process. This optimized formula is supported by gold standard clinical evidence illustrating its ability to improve Lower Urinary Tract Symptons (LUTS) typically associated with Benign Prostatic Hyperplasia (BPH).

In a double-blind, randomized, placebo controlled intervention study, researchers gave Flowens to men with moderate LUTS typically associated with BPH that weren’t using any other therapy to address their symptoms. Overall, consuming Flowens once daily showed statistically significant improvements in the key clinical marker for BPH/LUTS by up to 44 %– the International Prostate Symptom Score (IPSS). Both doses also showed statistically significant improvements in uroflowmetry markers such as post-void residual volume (PRV) and bladder volume (VOL).

“Flowens delivers clinical results without the unwanted sexual side effects commonly associated with pharmaceutical drugs and the current phytotherapy,” said Dan Souza, Senior Director of Sales and Marketing for Naturex-DBS. “More than 96% of the subjects who observed symptom improvements, such as frequency, urge incontinence, weak stream, urinary retention, etc., would recommend Flowens to a friend.”